CompletedNCT03572426
Official study titleIon Channel Genetic Biomarkers: Diagnostic Capabilities in the Assessment of Bipolar Disorder
This study has finished and is no longer accepting participants.
In AuroraBipolarityObservational studyAges 18–80
- Countries
- United States
- Sponsor
- University of Colorado, Denver
CompletedNCT00723450
Official study titleThe Evaluation of Lamictal as an Add-on Treatment for Bipolar I Disorder in Children and Adolescents, 10 to 17 Years of Age
This study has finished and is no longer accepting participants.
Multiple locations, including DothanBipolarityMedication studyAges 10–17
- Countries
- United States
- Sponsor
- GlaxoSmithKline
CompletedNCT00238576
Official study titleLamotrigine in the Treatment of Bipolar Disorder in Women of Reproductive Age
This study has finished and is no longer accepting participants.
In StanfordBipolarityObservational studyAges 18–45
- Countries
- United States
- Sponsor
- Stanford University
CompletedNCT01737268
What is this study about?Researchers studied FK949E to find out how it affected depression symptoms in older adults with bipolarity.
This study has finished and is no longer accepting participants.
Multiple locations, including ChibaBipolarityMedication studyAges 65+
- Countries
- Japan
- Sponsor
- Astellas Pharma Inc
Active Not RecruitingNCT04447807
Official study titleRehabilitating Social Cognition: A Randomized Control Study Using Metacognitive Training in a Group Format With Bipolar Disorder Patients.
This study is no longer accepting new participants.
In São PauloBipolarityBehavioural studyAges 18–60
- Countries
- Brazil
- Sponsor
- University of Sao Paulo
CompletedNCT02644577
Official study titleMetformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients
This study has finished and is no longer accepting participants.
In ShenyangBipolarityMedication studyAges 18–45
- Countries
- China
- Sponsor
- China Medical University, China
CompletedNCT03507647
Official study titleMindfulness Based Cognitive Therapy for Bipolar Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including NijmegenBipolarityBehavioural studyAges 18+
- Countries
- Netherlands
- Sponsor
- Radboud University Medical Center
CompletedNCT07297056
Official study titleThe Effect of Mindfulness-Based Psychoeducation Programme on Mindfulness, Self-Compassion and Forgiveness Tendencies of Patients With Bipolar Disorder: A Randomised Controlled Trial
This study has finished and is no longer accepting participants.
In AydinBipolarityInterventional studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Ömer USLU
CompletedNCT01764035
Official study titleThe Effects of Mindfulness on Disrupted Sleep in Bipolar Disorder
This study has finished and is no longer accepting participants.
In BostonBipolarityBehavioural studyAges 18–65
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT01770704
Official study titleChinese Observation Study of the Clinical Management of Bipolar Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including BeijingBipolarityObservational studyAges 18+
- Countries
- China
- Sponsor
- AstraZeneca
CompletedNCT06256367
Official study titleCariprazine Real-world Use in Bipolar I Disorder: Effectiveness, Functioning, Quality of Life, and Tolerability
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamBipolarityObservational studyAges 18+
- Countries
- United States, Canada
- Sponsor
- AbbVie
CompletedNCT01710709
What is this study about?This study evaluated the effectiveness of Aripiprazole for people with bipolarity.
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamBipolarityMedication studyAges 18–65
- Countries
- United States, France, Canada, + 7 others
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)